Substance Abuse and Mental Health Services Administration. (2023) Coronavirus (Covid-19).
External website: https://www.samhsa.gov/coronavirus
SAMHSA recognizes the challenges posed by COVID-19 and is providing the following guidance and resources to assist US individuals, providers, communities and states. SAMHSA stands ready to assist in any manner possible.
Opioid Treatment Programs (OTPs)
- 2021 Methadone Take-Home Flexibilities Extension Guidance (Updated July 2023)
- Opioid Treatment Program (OTP) Guidance (March 16, 2020) (PDF | 216 KB)
- OTP Guidance for Patients Quarantined at Home with the Coronavirus (PDF | 160 KB)
- FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency (PDF | 202 KB)
- Sample OTP COVID-19 FAQs (PDF | 341 KB)
- Use of Telemedicine While Providing Medication-Assisted Treatment (PDF | 146 KB)
Item Type
Webpage
Publication Type
International
Drug Type
Substances (not alcohol/tobacco), Opioid
Intervention Type
General / Comprehensive, Drug therapy, Treatment method, Harm reduction
Source
Date
July 2023
Publisher
SAMHSA
Corporate Creators
Substance Abuse and Mental Health Services Administration
Place of Publication
Rockville, MD
EndNote
Subjects
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
N Communication, information and education > Telehealth / Telemedicine / mHealth / eHealth
VA Geographic area > United States
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
N Communication, information and education > Telehealth / Telemedicine / mHealth / eHealth
VA Geographic area > United States
Repository Staff Only: item control page